The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia
NCT00002276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.
Conditions
- HIV Infections
- Hemophilia A
Interventions
- DRUG
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip
NCT04592692 ·Status: UNKNOWN ·Phase: PHASE2
-
A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
NCT05027230 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
NCT03741881 ·Status: COMPLETED
-
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542 ·Status: RECRUITING
-
Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients
NCT01333111 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
NCT02476942 ·Status: COMPLETED
-
Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects
NCT01272206 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
NCT00782470 ·Status: COMPLETED
-
Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens
NCT02314325 ·Status: UNKNOWN ·Phase: PHASE4
-
Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A
NCT02971930 ·Status: COMPLETED
-
Epidemiology and Immunology of Hemophilia A Inhibitors
NCT00005518 ·Status: COMPLETED
-
Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors
NCT01234545 ·Status: COMPLETED
-
A Feasibility Study to Collect Data in Patients With Haemophilia
NCT00798499 ·Status: COMPLETED
-
A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
NCT04747964 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Inhibitor Specificity in Hemophilia A
NCT00151385 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
NCT06289166 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
NCT01439971 ·Status: COMPLETED ·Phase: PHASE1
-
Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients
NCT02540187 ·Status: COMPLETED
-
Study Evaluating The Safety Of Xyntha In Usual Care Settings
NCT00765726 ·Status: TERMINATED ·Phase: PHASE4
-
TFPI Levels in Haemophilia A and B Patients
NCT04570696 ·Status: UNKNOWN
-
Liver Biopsy Following Gene Therapy For Hemophilia
NCT05932914 ·Status: NOT_YET_RECRUITING
-
A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
NCT04560933 ·Status: COMPLETED
-
Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A
NCT00717626 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Health-related Outcome of rFVIIIFc Prophylaxis
NCT04583930 ·Status: UNKNOWN
-
Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A
NCT02697370 ·Status: COMPLETED ·Phase: PHASE4